More MS news articles for August 2002

2nd International Ion Channel Drug Discovery Conference & Exposition To Take Place October 24-25, 2002, in Princeton, NJ

http://www.prnewswire.com/cgi-bin/stories.pl?ACCT=104&STORY=/www/story/08-05-2002/0001777390&EDATE=

Aug. 5, 2002
PRINCETON, N.J.,
PRNewswire

The latest developments in Ion Channel research at the discovery, preclinical, and clinical stages will be the focus of the 2nd International "Ion Channels in Drug Discovery & Development" taking place in Princeton, NJ on October 24-25, 2002, announces Strategic Research Institute.

Research over the past decade has revealed that ion channels have therapeutic potential in a number of diseases such as Parkinson's, Alzheimer's, neuropathic pain, sickle cell disease, and many others. The meeting will cover topics such as automated electrophysiology, emerging targets & pharmacology, and preclinical & clinical development of Ion Channel compounds, with pharmaceutical, biotech, and academic scientists revealing their newest findings.

Highlights of the meeting include:

NEW! The Application and Data Generated by Automated Patch Clamp Technologies
Computational Studies of the Potassium Channel

Altered K+ Channel Expression in Myelin-Reactive T Cells in Multiple Sclerosis: Target for Immunotherapy

Presenting papers on behalf of the industry will be Abbott Laboratories, AstraZeneca, Merck Research Laboratories, Amersham Biosciences, Schering-Plough Research Institute, Pharmacia, Axon Instruments, NeuroMed Technologies, Icagen, Evotec OAI, NeuroSearch, and Zyomyx. National Cancer Institute, NYU School of Medicine, Weill Medical College, UC Irvine, and UC San Diego will represent the academia.

To receive the full agenda and/or register for the conference, please contact Jon E. Liong of Strategic Research Institute 212-967-0095, x243 (please include name, corporate affiliation, mailing address, and fax number).

SOURCE

Strategic Research Institute
Web Site: http://www.srinstitute.com